Sonja Baumli

2.3k citations

19 papers · 1.8k indexed · h-index 17

Impact in

Virology top 5%
Molecular Biology top 5%
- RNA Research and Splicing
- Genomics and Chromatin Dynamics
- RNA and protein synthesis mechanisms
- RNA modifications and cancer
- Protein Degradation and Inhibitors
- Ubiquitin and proteasome pathways

Papers in ⓘ

Molecular Biology 17
- RNA modifications and cancer 6
- Genomics and Chromatin Dynamics 5
- RNA and protein synthesis mechanisms 4
- RNA Research and Splicing 4
- Biochemical and Molecular Research 3
Oncology 11
- Cancer-related Molecular Pathways 9

Co-authors: Patrick Cramer (8 shared papers)Sabine Hoeppner (3 shared papers)Jane Endicott (6 shared papers)Tomislav Kamenski (2 shared papers)L.N. Johnson (3 shared papers)Anton Meinhart (1 shared paper)Alison J. Hole (5 shared papers)Vladimı́r Kryštof (1 shared paper)
Journals: The EMBO Journal (2 papers)Journal of Medicinal Chemistry (2 papers)Genes & Cancer (1 paper)Nature Structural & Molecular Biology (1 paper)Structure (1 paper)
Partner nations: United Kingdom Germany Australia

In The Last Decade

Sonja Baumli

19 papers receiving 1.7k citations

Peers

Countries citing papers authored by Sonja Baumli

Since Specialization

Citations

This map shows the geographic impact of Sonja Baumli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sonja Baumli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sonja Baumli more than expected).

Fields of papers citing papers by Sonja Baumli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sonja Baumli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sonja Baumli. The network helps show where Sonja Baumli may publish in the future.

Co-authors

The 25 scholars most cited alongside Sonja Baumli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sonja Baumli Line = papers co-authored together Sonja Baumli links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work
1	The structure of P‐TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation The EMBO Journal ·Sonja Baumli, Graziano Lolli, E.D. Lowe, Sonia Troiani, Luisa Rusconi, Alex N. Bullock, J.E. Debreczeni, Stefan Knapp, L.N. Johnson	2008	286
2	A structural perspective of CTD function Genes & Development ·Anton Meinhart, Tomislav Kamenski, Sabine Hoeppner, Sonja Baumli, Patrick Cramer	2005	265
3	Structure of Eukaryotic RNA Polymerases Annual Review of Biophysics ·Patrick Cramer, Karim‐Jean Armache, Sonja Baumli, S. Benkert, Florian Brueckner, Claudia Buchen, G.E. Damsma, Stefan Dengl, S. Geiger, Anna J. Jasiak, Anass Jawhari, Stefan Jennebach, Tomislav Kamenski, Hubert Kettenberger, Claus‐D. Kuhn, Elaine M. Taylor, Kristin Leike, J.F. Sydow, Alessandro Vannini	2008	222
4	Functional Architecture of RNA Polymerase I Cell ·Claus‐D. Kuhn, S. Geiger, Sonja Baumli, Marco Gartmann, Jochen Gerber, Stefan Jennebach, Thorsten Mielke, Herbert Tschochner, Roland Beckmann, Patrick Cramer	2007	169
5	Substituted 4-(Thiazol-5-yl)-2-(phenylamino)pyrimidines Are Highly Active CDK9 Inhibitors: Synthesis, X-ray Crystal Structures, Structure–Activity Relationship, and Anticancer Activities Journal of Medicinal Chemistry ·Hao Shao, Shenhua Shi, Shi‐Liang Huang, Alison J. Hole, Abdullahi Y. Abbas, Sonja Baumli, Xiangrui Liu, Frankie Lam, David Foley, Peter M. Fischer, M.E.M. Noble, Jane Endicott, Chris Pepper, Shudong Wang	2013	104
6	Perspective of Cyclin-dependent kinase 9 (CDK9) as a Drug Target Current Pharmaceutical Design ·Vladimı́r Kryštof, Sonja Baumli, Robert Fürst	2012	95
7	Halogen Bonds Form the Basis for Selective P-TEFb Inhibition by DRB Chemistry & Biology ·Sonja Baumli, Jane Endicott, L.N. Johnson	2010	90
8	Structure and VP16 binding of the Mediator Med25 activator interaction domain Nature Structural & Molecular Biology ·Erika Vojnic, André Mourão, Martin Seizl, Bernd Simon, Larissa Wenzeck, Laurent Larivière, Sonja Baumli, Karen Baumgart, Michael Meisterernst, Michael Sattler, Patrick Cramer	2011	88
9	CDK Inhibitors Roscovitine and CR8 Trigger Mcl-1 Down-Regulation and Apoptotic Cell Death in Neuroblastoma Cells Genes & Cancer ·Karima Bettayeb, Dianne Baunbæk, Claire Delehouzé, Nadège Loaëc, Alison J. Hole, Sonja Baumli, Jane Endicott, Sétha Douc‐Rasy, Jean Bénard, Nassima Oumata, Hervé Galons, Laurent Meijer	2010	68
10	A Conserved Mediator Hinge Revealed in the Structure of the MED7·MED21 (Med7·Srb7) Heterodimer Journal of Biological Chemistry ·Sonja Baumli, Sabine Hoeppner, Patrick Cramer	2005	61
11	Comparative Structural and Functional Studies of 4-(Thiazol-5-yl)-2-(phenylamino)pyrimidine-5-carbonitrile CDK9 Inhibitors Suggest the Basis for Isotype Selectivity Journal of Medicinal Chemistry ·Alison J. Hole, Sonja Baumli, Hao Shao, Shenhua Shi, Shi‐Liang Huang, Chris Pepper, Peter M. Fischer, Shudong Wang, Jane Endicott, M.E.M. Noble	2012	55
12	The CDK9 C-helix Exhibits Conformational Plasticity That May Explain the Selectivity of CAN508 ACS Chemical Biology ·Sonja Baumli, Alison J. Hole, M.E.M. Noble, Jane Endicott	2012	51
13	Identification, structure, and functional requirement of the Mediator submodule Med7N/31 The EMBO Journal ·Tobias Koschubs, Martin Seizl, Laurent Larivière, Fabian Kurth, Sonja Baumli, Dietmar E. Martin, Patrick Cramer	2008	47
14	Structure of the Mediator Subunit Cyclin C and its Implications for CDK8 Function Journal of Molecular Biology ·Sabine Hoeppner, Sonja Baumli, Patrick Cramer	2005	44
15	Herpes Simplex Virus 1 (HSV-1) ICP22 Protein Directly Interacts with Cyclin-Dependent Kinase (CDK)9 to Inhibit RNA Polymerase II Transcription Elongation PLoS ONE ·Justyna Zaborowska, Sonja Baumli, Clélia Laitem, Dawn O’Reilly, Peter H. Thomas, Peter O’Hare, Shona Murphy	2014	41
16	Preparation and topology of the Mediator middle module Nucleic Acids Research ·Tobias Koschubs, Kristina Lorenzen, Sonja Baumli, Saana Sandström, Albert J. R. Heck, Patrick Cramer	2010	35
17	The CDK9 Tail Determines the Reaction Pathway of Positive Transcription Elongation Factor b Structure ·Sonja Baumli, Alison J. Hole, Lan-Zhen Wang, M.E.M. Noble, Jane Endicott	2012	27
18	The binding of flavopiridol to blood serum albumin Chirality ·Daniel Myatt, Louise Johnson, Sonja Baumli, Giuliano Siligardi	2010	9
19	Flavopiridol binding to P-TEFb (CDK9/cyclin T1) Acta Crystallographica Section A Foundations of Crystallography ·L.N. Johnson, Sonja Baumli, Graziano Lolli, E.D. Lowe	2008	1

About Sonja Baumli

Sonja Baumli is a scholar working on Molecular Biology, Oncology, Genetics, Genetics and Materials Chemistry, having authored 19 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (9 papers), RNA modifications and cancer (6 papers), Genomics and Chromatin Dynamics (5 papers), RNA and protein synthesis mechanisms (4 papers), RNA Research and Splicing (4 papers), Biochemical and Molecular Research (3 papers), Bacterial Genetics and Biotechnology (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). The work is most often cited by research in Virology (98 citations), Molecular Biology (1.4k citations), Oncology (404 citations), Cell Biology (174 citations) and Structural Biology (9 citations). Sonja Baumli has collaborated with scholars based in United Kingdom, Germany and Australia. Frequent co-authors include Patrick Cramer, Sabine Hoeppner, Jane Endicott, Tomislav Kamenski, L.N. Johnson, Anton Meinhart, Alison J. Hole, Vladimı́r Kryštof, Alex N. Bullock and Luisa Rusconi. Their work appears in journals such as The EMBO Journal, Journal of Medicinal Chemistry, Genes & Cancer, Nature Structural & Molecular Biology and Structure.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact